Delivery Order SPE2DB22D2211-SPE2DB25FSENE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100, valued at $1,242.74. This is a firm fixed price delivery order with an ultimate completion date of July 23, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,518.01 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,144.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 29, 2025. The delivery order was issued on July 28, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units, with a contract ceiling value of $1,601.78. This firm fixed price delivery order is not set-aside and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 units. This non-competitive delivery order, valued at $1,151.19 with a firm fixed price structure, was executed on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,441.00 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance will be completed by September 11, 2025, at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100, with a ceiling value of $1,687.28. This firm fixed price delivery order, which represents a non-set-aside competitive award, is expected to be completed by August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of dextroamphetamine-amphetamine 15 mg tablets in quantities of 100 units, with a contract value of $2,381.06 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a standard pharmaceutical procurement through the federal medical supply chain with no set-aside designation. AmerisourceBergen Drug Corp,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of dextroamphetamine tablets (5 mg) under a firm fixed price contract. This competitively awarded delivery order, issued on July 21, 2025, has a ceiling value of $1,033.08 and an ultimate completion date of July 22, 2025. The contract is classified as a child contract, indicating it is issued under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSENEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units, with a ceiling value of $1,461.37. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, delivering essential medications and medical supplies to support military and veteran healthcare systems. The company's comprehensive pharmaceutical portfolio under the DLA contract encompasses a wide range of therapeutic categories, including controlled substances such as dextroamphetamine-amphetamine for the treatment of attention deficit disorders. The delivery order structure allows the federal government to procure specific quantities of medications as needed while maintaining firm pricing, ensuring cost predictability and supply chain continuity for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/9/25 |